Inorganic Chemistry
Article
3.19−2.56 (br, 12H), 2.46−1.82 (br, 10H), 1.48 (s, 9H), 1.29 (s, 9H),
1.21 (s, 18H). 13C NMR (101 MHz, DMSO): δ 170.54, 169.90,
158.61, 152.55, 148.94, 140.89, 132.47, 131.21, 125.02, 123.39, 117.91,
114.21, 94.17, 85.88, 79.64, 58.04, 57.96, 57.26, 54.93, 50.42, 50.38,
28.28, 28.13, 28.08. MALDI-TOF MS: calcd for [M + Na+] 840.5470,
found 840.5500.
7.65 (s, 1H), 7.61 (s, 1H), 7.56 (d, J = 8.7 Hz, 2H), 7.40 (dd, J = 5.1,
1.1 Hz, 1H), 7.32 (s, 2H), 4.61 (s, 2H), 3.71 (m, 6H), 2.66 (br, 12H),
2.40−1.80 (m, 14H), 1.30 (s, 9H), 1.22 (s, 18H). 13C NMR (101
MHz, DMSO) δ 189.99, 170.54, 169.88, 165.43, 158.65, 148.96,
141.07, 140.54, 135.79, 132.66, 132.33, 131.10, 127.92, 125.10, 124.25,
123.45, 120.05, 115.76, 93.94, 86.27, 58.07, 57.87, 57.21, 55.56,50.59,
50.40, 50.34, 29.34, 28.26, 28.11, 25.57, 23.73. MALDI-TOF MS:
calcd for [M + H+] 1023.5783, found 1023.5765.
Synthesis of 2,2′,2′′-(10-((4-((4-Aminophenyl)ethynyl)pyridin-2-
yl)methyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)tris(N-(tert-
butyl)acetamide) (10). To a solution of tert-butyl (4-((2-((4,7,10-
tris(2-(tert-butylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-
yl)methyl)pyridin-4-yl)ethynyl)phenyl)carbamate (9; 1.00 g, 1.22
mmol) in MeOH (30 mL) was added 6 M aqueous HCl (30 mL)
under an ice bath. The reaction mixture was warmed to room
temperature and stirred for 6 h. The pH of the solution was adjusted
to 9 with 1.0 M aqueous NaOH, the solution was extracted with DCM
(100 mL × 3), and the extracted material was dried over anhydrous
Na2SO4. The solvent was removed, and the residue was purified by
chromatography on neutral Al2O3 with elution by DCM/methanol
(50/1, v/v), giving the product as a yellow solid (750 mg, 85.5%
yield). 1H NMR (400 MHz, DMSO): δ 8.31 (d, J = 5.1 Hz, 1H), 7.82
(s, 2H), 7.65 (s, 1H), 7.43 (s, 1H), 7.28 (dd, J = 5.1, 1.4 Hz, 1H), 7.21
(d, J = 8.6 Hz, 2H), 6.56 (d, J = 8.6 Hz, 2H), 5.75 (s, 2H), 3.65 (br,
2H), 2.72 (br, 12H), 2.19 (br, 10H), 1.30 (s, 9H), 1.21 (s, 18H). 13C
NMR (101 MHz, DMSO): δ 170.52, 169.93, 158.42, 150.40, 148.86,
133.15, 132.01, 124.53, 123.04, 113.58, 106.68, 96.54, 84.62, 58.03,
57.36, 54.93, 50.43, 50.39, 28.28, 28.13. MALDI-TOF MS: calcd for
[M + H+] 718.5127, found 718.5089.
Synthesis of 2-Oxo-2-(4-((4-((2-((4,7,10-tris(2-(tert-butylamino)-
2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl)methyl)pyridin-4-
yl)ethynyl)phenyl)carbamoyl)phenyl)ethyl Pyrrolidine-1-carbodi-
thioate (11). To a solution of 4-(2-((pyrrolidine-1-carbonothioyl)-
thio)acetyl)benzoic acid (3; 172 mg, 0.56 mmol) in 25 mL of dry
MeCN were added DIPEA (0.24 mL, 1.39 mmol), EDCI (160 mg,
0.84 mmol), and HOBt (112 mg, 0.84 mmol). The reaction mixture
was stirred for 0.5 h at room temperature, and 2,2′,2′′-(10-((4-((4-
aminophenyl)ethynyl)pyridin-2-yl)methyl)-1,4,7,10-tetraazacyclodo-
decane-1,4,7-triyl)tris(N-(tert-butyl)acetamide) (10; 200 mg, 0.28
mmol) was added. The reaction mixture was stirred for another 36
h at room temperature. Most of the solvent was removed under
reduced pressure, 30 mL of water was added, extraction with DCM
(30 mL × 3) was performed, and the extractant was dried over
anhydrous Na2SO4. The solvent was removed, and the residue was
purified by chromatography on neutral Al2O3 with DCM/methanol
(50/1, v/v) as eluent, giving the product as a yellow solid (164 mg,
58.6% yield). 1H NMR (400 MHz, DMSO): δ 10.70 (s, 1H), 8.39 (d, J
= 5.0 Hz, 1H), 8.19 (d, J = 8.5 Hz, 2H), 8.09 (d, J = 8.5 Hz, 2H), 7.91
(d, J = 8.8 Hz, 2H), 7.82 (s, 2H), 7.63 (d, J = 8.3 Hz, 2H), 7.59 (d, J =
8.6 Hz, 2H), 7.41 (d, J = 6.2 Hz, 1H), 4.98 (s, 2H), 3.73 (m, 6H), 2.66
(m, 12H), 2.39−1.87 (m, 14H), 1.30 (s, 9H), 1.22 (s, 18H). 13C NMR
(101 MHz, DMSO): δ 192.84, 189.99, 170.55, 169.89, 165.12, 158.67,
148.97, 140.23, 138.59, 133.14, 132.39, 131.06, 128.24, 125.14, 123.47,
120.22, 116.17, 113.56, 93.83, 86.40, 58.10, 57.90, 57.22, 55.40, 54.93,
50.81, 50.41, 50.35, 49.39, 43.35, 28.27, 28.12, 25.74, 23.88. MALDI-
TOF MS: calcd for [M + Na+] 1031.5334, found 1031.5319.
Synthesis of 2-((3′,6′-Bis(diethylamino)-3-oxospiro[isoindoline-
1,9′-xanthen]-2-yl)imino)-2-(4-((4-((2-((4,7,10-tris(2-(tert-butylami-
no)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl)methyl)-
pyridin-4-yl)ethynyl)phenyl)carbamoyl)phenyl)ethyl Pyrrolidine-1-
carbodithioate (13; GB001). Rhodamine B (43 mg, 0.10 mmol)
and POCl3 (0.20 mL) were refluxed in 1,2-dichloroethane (4 mL) for
5 h, and then the solvent was removed. The obtained crude rhodamine
B acid chloride was dissolved in 10 mL of dry DCM together with
trimethylamine (0.30 mL) and 2-hydrazono-2-(4-((4-((2-((4,7,10-
tris(2-(tert-butylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-
yl)methyl)pyridin-4-yl)ethynyl)phenyl)carbamoyl)phenyl)ethyl pyrro-
lidine-1-carbodithioate (12; 50 mg, 0.05 mmol) and stirred for 12 h at
room temperature. After addition of 10 mL of water, extraction with
DCM (10 mL × 4), and drying over anhydrous Na2SO4, the crude
product was purified by chromatography on silica gel with DCM/
MeOH (100/1 to 50/1, v/v) to give the desired product as a red solid
(50 mg, 71.0% yield). 1H NMR (400 MHz, DMSO): δ 10.51 (s, 1H),
8.38 (d, J = 5.1 Hz, 1H), 7.88 (m, 7H), 7.62 (m, 8H), 7.39 (d, J = 5.8
Hz, 1H), 7.20 (d, J = 6.8 Hz, 1H), 6.49 (d, J = 8.8 Hz, 2H), 6.43−6.27
(m, 4H), 4.73 (s, 2H), 3.74 (m, 4H), 3.31 (q, 8H), 2.71 (br, 14H),
2.33 (br, 8H), 2.00−1.77 (br, 6H), 1.30 (s, 9H), 1.21 (s, 18H), 1.08 (t,
J = 6.9 Hz, 12H). 13C NMR (101 MHz, DMSO): δ 189.43, 170.56,
169.90, 165.51, 165.01, 160.36, 158.68, 153.15, 150.81, 148.97, 148.35,
140.26, 138.02, 136.26, 133.37, 132.38, 131.07, 129.77, 128.93, 128.27,
127.86, 127.17, 125.14, 124.06, 123.47, 123.19, 120.08, 116.04, 107.93,
105.97, 97.24, 93.84, 86.36, 66.97, 58.10, 57.88, 57.24, 55.78, 54.92,
50.41, 50.36, 30.71, 28.26, 28.12, 25.50, 23.65, 12.41. MALDI-TOF
MS: calcd for [M + Na+] 1469.7753, found 1469.7783
Synthesis of GBYb001 (14a). To a solution of 13 (GB001; 14 mg.
0.01 mmol) in 1.0 mL of MeOH was added 0.01 M aqueous YbCl3
(1.05 mL, 0.0105 mmol), and the mixture was stirred for 24 h at room
temperature. The solvent was removed, and the residue was dissolved
in 2 mL of water and washed with DCM (2 mL × 3). The water was
removed, and the residue was dried under vacuum, giving a purple
solid as product (15 mg, 83.3% yield). ESI-MS: calcd for [M − H2O −
3Cl− − 2H+] 1618.7, found 1618.9; calcd for [M − H2O − 3Cl−
−
H+]/2 809.9. HPLC retention time: 16.07 min.
Synthesis of GBLa001 (14b). To a solution of 13 (GB001; 5 mg,
0.0035 mmol) in 0.7 mL of MeOH was added 0.005 M aqueous LaCl3
(0.71 mL, 0.00354 mmol), and the mixture was stirred for 24 h at
room temperature. The solvent was removed, and the residue was
dissolved in 2 mL of water and washed with DCM (3 × 1 mL). The
water was removed, and the residue was dried under vacuum, giving a
1
purple solid as the product (5.8 mg, 93.3% yield). H NMR (400
Synthesis of 2-Hydrazono-2-(4-((4-((2-((4,7,10-tris(2-(tert-butyla-
mino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl)methyl)-
pyridin-4-yl)ethynyl)phenyl)carbamoyl)phenyl)ethyl Pyrrolidine-1-
carbodithioate (12). To a solution of 2-oxo-2-(4-((4-((2-((4,7,10-
tris(2-(tert-butylamino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-
yl)methyl)pyridin-4-yl)ethynyl)phenyl)carbamoyl)phenyl)ethyl pyrro-
lidine-1-carbodithioate (11; 230 mg, 0.23 mmol) in THF (12 mL) and
ethanol (12 mL) were added hydrazine hydrate (0.23 mL) and acetic
acid (0.23 mL). Then the reaction mixture was heated to reflux and
stirred for 2 h. The contents were cooled, and most of the solvent was
removed. A 40 mL portion of water and 3 mL of saturated aqueous
NaHCO3 were added, followed by extraction with DCM (30 mL × 3)
and drying over anhydrous Na2SO4. The solvent was removed, and the
residue was chromatographed on neutral Al2O3 with DCM/methanol
(50/1, v/v) as eluent, giving the product as a yellow solid (128 mg,
54.9% yield). 1H NMR (400 MHz, DMSO): δ 10.46 (s, 1H), 8.38 (d, J
= 5.1 Hz, 1H), 7.92 (m, 4H), 7.83 (s, 2H), 7.75 (d, J = 8.6 Hz, 2H),
MHz, DMSO): δ 10.51 (s, 1H), 8.38 (d, J = 5.2 Hz, 1H), 7.95−7.76
(m, 7H), 7.74−7.52 (m, 8H), 7.39 (d, J = 5.2 Hz, 1H), 7.20 (d, J = 7.2
Hz, 1H), 6.49 (d, J = 8.9 Hz, 2H), 6.42−6.27 (m, 4H), 4.72 (s, 4H),
3.74 (s, 8H), 3.31−3.29 (m, 14H), 2.65 (d, J = 14.3 Hz, 8H), 2.28 (d, J
= 35.9 Hz, 6H), 1.89 (dd, J = 21.8, 6.3 Hz, 9H), 1.30 (s, 1H), 1.18 (d, J
= 26.4 Hz, 18H), 1.08 (7, J = 6.9 Hz, 12H). HPLC retention time:
16.06 min.
Synthesis of GBYb002 (15). To a solution of 11 (GB002; 6.5 mg.
0.0065 mmol) in 1 mL of MeOH was added 0.005 M aqueous YbCl3
(1.00 mL, 0.0065 mmol), and the mixture was stirred for 24 h at room
temperature. The solvent was removed, and the residue was dissolved
in 2 mL of water and washed with DCM (3 × 1 mL). The water was
removed, and the residue was dried under vacuum, giving a yellow
solid as the product (8.0 mg, 92.0% yield). HPLC retention time:
15.02 min.
H
Inorg. Chem. XXXX, XXX, XXX−XXX